VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan )
Also on site :
- Legendary Hard Rock Band Racks Up the Heavy Metal as Iconic Album Hits Sales of 20 Million
- Azul transforms for the future as Company reaches agreements on financial reorganization with key stakeholders, including its lenders, largest lessor, and strategic partners United Airlines and American Airlines
- Plush £150m superyacht laden with luxuries like jacuzzi & helipad owned by ex-Starbucks CEO squeezes through Dutch canal